Procurement Summary
Country: Kazakhstan
Summary: Purchase of Medicines, Medicines, Medical Products in Accordance with Technical Specifications in Agreement with the Customer, Amt: 687699.00
Deadline: 15 Apr 2026
Posting Date: 14 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 139485829
Document Ref. No.: 16779037-1
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: KZT 687699.00
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Lots: Fluconazole - Capsules, 150 mg, No. 1. Quantity: 30 packs. | Ciprofloxacin, dexamethasone - Ear drops 3 mg/ml 10 ml No. 1. Ear drops 0.3% in the form of a transparent, viscous, colorless to colorless solution with a slightly yellowish tint. Treatment of acute and chronic infectious diseases of the ear: otitis externa; acute and chronic otitis media. Prevention of infectious otitis before and after surgery, with ear injuries, removal of a foreign body from the external auditory canal, accompanied by damage to ear tissue. Quantity: 30 bottles. | Film-coated tablets, 500 mg, No. 10, One tablet contains the active substance - ciprofloxacin hydrochloride 291.51 mg or 583.00 mg, equivalent to ciprofloxacin 250 mg or 500 mg respectively, excipients: microcrystalline cellulose RN 102, corn starch, povidone K 30, anhydrous colloidal silicon dioxide (Aerosil 200), magnesium stearate, croscarmellose sodium composition of film shell No. 1 (Sepifilm LP770): hydroxypropyl methylcellulose, microcrystalline cellulose, stearic acid, titanium dioxide (E 171). Quantity: 30 packs. | Captopril - Tablets, 25 mg, No. 20. Quantity: 50 packs. | Amoxicillin - Lozenges, Active substances - Benzocoin, Enoxolone, Chlorhexidine hydrochloride, Purpose - ARVI, Infectious and inflammatory diseases of the oral cavity and pharynx, Indications - For infectious and inflammatory diseases of the oral cavity and pharynx. Local and symptomatic treatment...
Documents
Tender Notice